MGTX Latest Press Releases

-- October 27, 2026 --

MeiraGTx Announces Four Posters at the European Society of Gene and Cell Therapy (ESGCT) 2026 Annual Congress and the Network of Excellence for ALS (NEALS) Annual Meeting Globe Newswire 8:00 AM

-- September 23, 2026 --

MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors Globe Newswire 8:00 AM

-- August 26, 2026 --

Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical PRNewswire 10:51 AM

-- August 13, 2026 --

MeiraGTx Reports Second Quarter 2026 Financial and Operational Results Globe Newswire 8:00 AM

-- August 11, 2026 --

Graviton BioScience Announces Clearance of Investigational New Drug (IND) for GV101 for the Treatment of Friedreich's Ataxia PRNewswire 10:30 AM

-- August 6, 2026 --

MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- July 7, 2026 --

MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec) Globe Newswire 7:30 AM

Market Data Delayed 15 Minutes